$KMPH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in KEMPHARM, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in KEMPHARM, INC. Get notifications about new insider transactions in KEMPHARM, INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 26 2020 | KMPH | KEMPHARM, INC | Clifton R. LaDuane | CFO, Secretary & Tr ... | Buy | P | 0.84 | 1,000 | 839 | 50,000 | 49 K to 50 K (+2.04 %) |
| Aug 18 2020 | KMPH | KEMPHARM, INC | Tierney David S | Director | Buy | P | 0.67 | 1,000 | 665 | 29,372 | 28.4 K to 29.4 K (+3.52 %) |
| Aug 18 2020 | KMPH | KEMPHARM, INC | Tierney David S | Director | Buy | P | 0.66 | 4,500 | 2,970 | 28,372 | 23.9 K to 28.4 K (+18.85 %) |
| Aug 18 2020 | KMPH | KEMPHARM, INC | Tierney David S | Director | Buy | P | 0.65 | 2,000 | 1,290 | 23,872 | 21.9 K to 23.9 K (+9.14 %) |
| Aug 18 2020 | KMPH | KEMPHARM, INC | Tierney David S | Director | Buy | P | 0.64 | 2,500 | 1,607 | 21,872 | 19.4 K to 21.9 K (+12.91 %) |
| Aug 18 2020 | KMPH | KEMPHARM, INC | Pascoe Richard W | Director | Buy | P | 0.64 | 1,800 | 1,152 | 28,573 | 26.8 K to 28.6 K (+6.72 %) |
| Aug 18 2020 | KMPH | KEMPHARM, INC | Pascoe Richard W | Director | Buy | P | 0.64 | 1,000 | 635 | 26,773 | 25.8 K to 26.8 K (+3.88 %) |
| Aug 18 2020 | KMPH | KEMPHARM, INC | Pascoe Richard W | Director | Buy | P | 0.63 | 7,200 | 4,565 | 25,773 | 18.6 K to 25.8 K (+38.77 %) |
| Aug 18 2020 | KMPH | KEMPHARM, INC | Clifton R. LaDuane | CFO, Secretary & Tr ... | Buy | P | 0.70 | 2,000 | 1,390 | 49,000 | 47 K to 49 K (+4.26 %) |
| Jun 22 2020 | KMPH | KEMPHARM, INC | Saluri Joseph | Director | Option Exercise | A | 0.27 | 30,000 | 8,130 | 30,000 | |
| Jun 22 2020 | KMPH | KEMPHARM, INC | Plooster Matthew R | Director | Option Exercise | A | 0.27 | 30,000 | 8,130 | 30,000 | |
| Jun 22 2020 | KMPH | KEMPHARM, INC | Pascoe Richard W | Director | Option Exercise | A | 0.27 | 30,000 | 8,130 | 30,000 | |
| Jun 22 2020 | KMPH | KEMPHARM, INC | Tierney David S | Director | Option Exercise | A | 0.27 | 30,000 | 8,130 | 30,000 | |
| Jun 22 2020 | KMPH | KEMPHARM, INC | Tierney David S | Director | Option Exercise | A | 0.27 | 30,000 | 8,130 | 30,000 | |
| Jun 11 2020 | KMPH | KEMPHARM, INC | Clifton R. LaDuane | CFO, Secretary & Tr ... | Buy | P | 0.19 | 1,500 | 288 | 47,000 | 45.5 K to 47 K (+3.30 %) |
| Jun 03 2020 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Buy | P | 0.19 | 110,000 | 20,790 | 1,888,117 | 1.8 M to 1.9 M (+6.19 %) |
| May 26 2020 | KMPH | KEMPHARM, INC | Clifton R. LaDuane | CFO, Secretary & Tr ... | Buy | P | 0.18 | 11,500 | 2,105 | 45,500 | 34 K to 45.5 K (+33.82 %) |
| Mar 25 2020 | KMPH | KEMPHARM, INC | Clifton R. LaDuane | CFO, Secretary & Tr ... | Buy | P | 0.22 | 1,000 | 218 | 34,000 | 33 K to 34 K (+3.03 %) |
| Mar 16 2020 | KMPH | KEMPHARM, INC | Sangiovanni Timothy J. | VP, Corporate Contr ... | Buy | P | 0.20 | 4,000 | 800 | 18,000 | 14 K to 18 K (+28.57 %) |
| Mar 12 2020 | KMPH | KEMPHARM, INC | Clifton R. LaDuane | CFO, Secretary & Tr ... | Buy | P | 0.25 | 8,000 | 2,010 | 33,000 | 25 K to 33 K (+32.00 %) |
| Mar 05 2020 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Buy | P | 0.33 | 2,500 | 825 | 1,778,117 | 1.8 M to 1.8 M (+0.14 %) |
| Mar 05 2020 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Buy | P | 0.33 | 4,500 | 1,484 | 1,775,617 | 1.8 M to 1.8 M (+0.25 %) |
| Mar 05 2020 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Buy | P | 0.33 | 3,000 | 990 | 1,771,117 | 1.8 M to 1.8 M (+0.17 %) |
| Mar 05 2020 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Buy | P | 0.33 | 4,500 | 1,502 | 1,768,117 | 1.8 M to 1.8 M (+0.26 %) |
| Mar 05 2020 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Buy | P | 0.33 | 4,500 | 1,499 | 1,763,617 | 1.8 M to 1.8 M (+0.26 %) |
| Mar 05 2020 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Buy | P | 0.33 | 3,000 | 1,002 | 1,759,117 | 1.8 M to 1.8 M (+0.17 %) |
| Mar 05 2020 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Buy | P | 0.33 | 3,000 | 1,003 | 1,756,117 | 1.8 M to 1.8 M (+0.17 %) |
| Feb 07 2020 | KMPH | KEMPHARM, INC | Guenther Sven | EVP, Research & Dev ... | Option Exercise | A | 0.37 | 160,000 | 59,840 | 160,000 | |
| Feb 07 2020 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Option Exercise | A | 0.37 | 420,000 | 157,080 | 420,000 | |
| Feb 07 2020 | KMPH | KEMPHARM, INC | Sangiovanni Timothy J. | VP, Corporate Contr ... | Option Exercise | A | 0.37 | 60,000 | 22,440 | 60,000 | |
| Feb 07 2020 | KMPH | KEMPHARM, INC | Clifton R. LaDuane | CFO, Secretary & Tr ... | Option Exercise | A | 0.37 | 160,000 | 59,840 | 160,000 | |
| Jan 02 2020 | KMPH | KEMPHARM, INC | Johnson Gordon K | Chief Business Offi ... | Buy | P | 0.39 | 10,000 | 3,884 | 40,000 | 30 K to 40 K (+33.33 %) |
| Jan 02 2020 | KMPH | KEMPHARM, INC | Johnson Gordon K | Chief Business Offi ... | Buy | P | 0.39 | 10,000 | 3,900 | 30,000 | 20 K to 30 K (+50.00 %) |
| Jan 02 2020 | KMPH | KEMPHARM, INC | Johnson Gordon K | Chief Business Offi ... | Buy | P | 0.39 | 10,000 | 3,884 | 40,000 | 30 K to 40 K (+33.33 %) |
| Jan 02 2020 | KMPH | KEMPHARM, INC | Johnson Gordon K | Chief Business Offi ... | Buy | P | 0.39 | 10,000 | 3,900 | 30,000 | 20 K to 30 K (+50.00 %) |
| Dec 30 2019 | KMPH | KEMPHARM, INC | Clifton R. LaDuane | CFO, Secretary & Tr ... | Buy | P | 0.42 | 2,250 | 938 | 25,000 | 22.8 K to 25 K (+9.89 %) |
| Dec 30 2019 | KMPH | KEMPHARM, INC | Clifton R. LaDuane | CFO, Secretary & Tr ... | Buy | P | 0.42 | 5,000 | 2,088 | 22,750 | 17.8 K to 22.8 K (+28.17 %) |
| Dec 30 2019 | KMPH | KEMPHARM, INC | Clifton R. LaDuane | CFO, Secretary & Tr ... | Buy | P | 0.42 | 5,000 | 2,085 | 17,750 | 12.8 K to 17.8 K (+39.22 %) |
| Sep 25 2019 | KMPH | KEMPHARM, INC | Clifton R. LaDuane | CFO, Secretary & Tr ... | Buy | P | 0.75 | 3,650 | 2,720 | 12,750 | 9.1 K to 12.8 K (+40.11 %) |
| Sep 25 2019 | KMPH | KEMPHARM, INC | Sangiovanni Timothy J. | VP, Corporate Contr ... | Buy | P | 0.74 | 3,000 | 2,220 | 6,000 | 3 K to 6 K (+100.00 %) |
| Sep 24 2019 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Buy | P | 0.79 | 5,000 | 3,938 | 1,753,117 | 1.7 M to 1.8 M (+0.29 %) |
| Sep 24 2019 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Buy | P | 0.78 | 5,000 | 3,919 | 1,748,117 | 1.7 M to 1.7 M (+0.29 %) |
| Sep 24 2019 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Buy | P | 0.79 | 5,000 | 3,939 | 1,743,117 | 1.7 M to 1.7 M (+0.29 %) |
| Sep 24 2019 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Buy | P | 0.79 | 5,000 | 3,938 | 1,753,117 | 1.7 M to 1.8 M (+0.29 %) |
| Sep 24 2019 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Buy | P | 0.80 | 5,000 | 3,977 | 1,738,117 | 1.7 M to 1.7 M (+0.29 %) |
| Sep 24 2019 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Buy | P | 0.78 | 5,000 | 3,919 | 1,748,117 | 1.7 M to 1.7 M (+0.29 %) |
| Sep 24 2019 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Buy | P | 0.79 | 15,000 | 11,849 | 1,733,117 | 1.7 M to 1.7 M (+0.87 %) |
| Sep 24 2019 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Buy | P | 0.79 | 5,000 | 3,939 | 1,743,117 | 1.7 M to 1.7 M (+0.29 %) |
| Sep 24 2019 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Buy | P | 0.78 | 5,000 | 3,922 | 1,718,117 | 1.7 M to 1.7 M (+0.29 %) |
| Sep 24 2019 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Buy | P | 0.80 | 5,000 | 3,977 | 1,738,117 | 1.7 M to 1.7 M (+0.29 %) |
| Sep 24 2019 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Buy | P | 0.78 | 10,000 | 7,839 | 1,713,117 | 1.7 M to 1.7 M (+0.59 %) |
| Sep 24 2019 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Buy | P | 0.79 | 15,000 | 11,849 | 1,733,117 | 1.7 M to 1.7 M (+0.87 %) |
| Sep 24 2019 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Buy | P | 0.78 | 5,000 | 3,922 | 1,718,117 | 1.7 M to 1.7 M (+0.29 %) |
| Sep 24 2019 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Buy | P | 0.78 | 10,000 | 7,839 | 1,713,117 | 1.7 M to 1.7 M (+0.59 %) |
| Sep 16 2019 | KMPH | KEMPHARM, INC | Clifton R. LaDuane | CFO, Secretary & Tr ... | Buy | P | 0.89 | 4,900 | 4,339 | 9,100 | 4.2 K to 9.1 K (+116.67 %) |
| Sep 16 2019 | KMPH | KEMPHARM, INC | Clifton R. LaDuane | CFO, Secretary & Tr ... | Buy | P | 0.86 | 100 | 86 | 4,200 | 4.1 K to 4.2 K (+2.44 %) |
| Sep 11 2019 | KMPH | KEMPHARM, INC | Clifton R. LaDuane | CFO, Secretary & Tr ... | Buy | P | 0.95 | 500 | 473 | 4,100 | 3.6 K to 4.1 K (+13.89 %) |
| Sep 09 2019 | KMPH | KEMPHARM, INC | Johnson Gordon K | Chief Business Offi ... | Buy | P | 0.83 | 5,000 | 4,126 | 20,000 | 15 K to 20 K (+33.33 %) |
| Sep 09 2019 | KMPH | KEMPHARM, INC | Johnson Gordon K | Chief Business Offi ... | Buy | P | 0.80 | 3,000 | 2,410 | 15,000 | 12 K to 15 K (+25.00 %) |
| Sep 09 2019 | KMPH | KEMPHARM, INC | Johnson Gordon K | Chief Business Offi ... | Buy | P | 0.82 | 2,000 | 1,633 | 12,000 | 10 K to 12 K (+20.00 %) |
| Sep 06 2019 | KMPH | KEMPHARM, INC | Clifton R. LaDuane | CFO, Secretary & Tr ... | Buy | P | 0.77 | 850 | 652 | 3,600 | 2.8 K to 3.6 K (+30.91 %) |
| May 14 2019 | KMPH | KEMPHARM, INC | Saluri Joseph | Director | Grant | A | 0.00 | 8,487 | 0 | 13,042 | 4.6 K to 13 K (+186.32 %) |
| May 14 2019 | KMPH | KEMPHARM, INC | Tierney David S | Director | Grant | A | 0.00 | 6,944 | 0 | 12,944 | 6 K to 12.9 K (+115.73 %) |
| May 14 2019 | KMPH | KEMPHARM, INC | Plooster Matthew R | Director | Grant | A | 0.00 | 8,487 | 0 | 16,655 | 8.2 K to 16.7 K (+103.91 %) |
| May 14 2019 | KMPH | KEMPHARM, INC | Pascoe Richard W | Director | Grant | A | 0.00 | 9,645 | 0 | 9,645 | 0 to 9.6 K |
| May 14 2019 | KMPH | KEMPHARM, INC | Thompson Danny L | Director | Grant | A | 0.00 | 8,873 | 0 | 23,513 | 14.6 K to 23.5 K (+60.61 %) |
| Apr 26 2019 | KMPH | KEMPHARM, INC | Saluri Joseph | Director | Option Exercise | A | 1.62 | 30,000 | 48,600 | 30,000 | |
| Apr 26 2019 | KMPH | KEMPHARM, INC | Tierney David S | Director | Option Exercise | A | 1.62 | 30,000 | 48,600 | 30,000 | |
| Apr 26 2019 | KMPH | KEMPHARM, INC | Pascoe Richard W | Director | Option Exercise | A | 1.62 | 30,000 | 48,600 | 30,000 | |
| Apr 26 2019 | KMPH | KEMPHARM, INC | Thompson Danny L | Director | Option Exercise | A | 1.62 | 30,000 | 48,600 | 30,000 | |
| Apr 26 2019 | KMPH | KEMPHARM, INC | Plooster Matthew R | Director | Option Exercise | A | 1.62 | 30,000 | 48,600 | 30,000 | |
| Feb 20 2019 | KMPH | KEMPHARM, INC | Johnson Gordon K | Chief Business Offi ... | Option Exercise | A | 2.29 | 60,000 | 137,400 | 60,000 | |
| Feb 08 2019 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Option Exercise | A | 2.66 | 60,000 | 159,600 | 60,000 | |
| Feb 08 2019 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Option Exercise | A | 2.66 | 420,000 | 1,117,200 | 420,000 | |
| Feb 08 2019 | KMPH | KEMPHARM, INC | Johnson Gordon K | Chief Business Offi ... | Option Exercise | A | 2.66 | 100,000 | 266,000 | 100,000 | |
| Feb 08 2019 | KMPH | KEMPHARM, INC | Guenther Sven | EVP, Research & Dev ... | Option Exercise | A | 2.66 | 160,000 | 425,600 | 160,000 | |
| Feb 08 2019 | KMPH | KEMPHARM, INC | Sangiovanni Timothy J. | VP, Corporate Contr ... | Option Exercise | A | 2.66 | 60,000 | 159,600 | 60,000 | |
| Feb 08 2019 | KMPH | KEMPHARM, INC | Clifton R. LaDuane | CFO, Secretary & Tr ... | Option Exercise | A | 2.66 | 160,000 | 425,600 | 160,000 | |
| Oct 15 2018 | KMPH | KEMPHARM, INC | Sangiovanni Timothy J. | VP, Corporate Contr ... | Buy | P | 2.50 | 1,500 | 3,750 | 3,000 | 1.5 K to 3 K (+100.00 %) |
| Oct 15 2018 | KMPH | KEMPHARM, INC | Sangiovanni Timothy J. | VP, Corporate Contr ... | Buy | P | 2.55 | 1,500 | 3,825 | 1,500 | 0 to 1.5 K |
| Oct 12 2018 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Gift | G | 0.00 | 18,139 | 0 | 123,217 | 141.4 K to 123.2 K (-12.83 %) |
| Oct 12 2018 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Gift | G | 0.00 | 32,172 | 0 | 21,466 | 53.6 K to 21.5 K (-59.98 %) |
| Oct 12 2018 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Buy | P | 2.55 | 5,000 | 12,764 | 1,703,117 | 1.7 M to 1.7 M (+0.29 %) |
| Oct 12 2018 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Gift | G | 0.00 | 18,139 | 0 | 1,698,117 | 1.7 M to 1.7 M (+1.08 %) |
| Oct 12 2018 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Gift | G | 0.00 | 32,172 | 0 | 1,679,978 | 1.6 M to 1.7 M (+1.95 %) |
| Oct 12 2018 | KMPH | KEMPHARM, INC | Johnson Gordon K | Chief Business Offi ... | Buy | P | 2.61 | 1,000 | 2,610 | 10,000 | 9 K to 10 K (+11.11 %) |
| Oct 12 2018 | KMPH | KEMPHARM, INC | Johnson Gordon K | Chief Business Offi ... | Buy | P | 2.65 | 1,000 | 2,647 | 9,000 | 8 K to 9 K (+12.50 %) |
| Oct 12 2018 | KMPH | KEMPHARM, INC | Johnson Gordon K | Chief Business Offi ... | Buy | P | 2.60 | 2,000 | 5,200 | 8,000 | 6 K to 8 K (+33.33 %) |
| Oct 11 2018 | KMPH | KEMPHARM, INC | Clifton R. LaDuane | CFO, Secretary & Tr ... | Buy | P | 2.54 | 650 | 1,652 | 2,750 | 2.1 K to 2.8 K (+30.95 %) |
| Oct 09 2018 | KMPH | KEMPHARM, INC | Delaware Street Capital Master ... | 10% Owner | Buy | P | 3.00 | 2,000,000 | 6,000,000 | 4,095,914 | 2.1 M to 4.1 M (+95.42 %) |
| Aug 01 2018 | KMPH | KEMPHARM, INC | Delaware Street Capital Master ... | 10% Owner | Buy | P | 4.00 | 304,283 | 1,217,132 | 2,095,914 | 1.8 M to 2.1 M (+16.98 %) |
| Jun 01 2018 | KMPH | KEMPHARM, INC | Clifton R. LaDuane | CFO, Secretary & Tr ... | Buy | P | 6.10 | 525 | 3,203 | 2,100 | 1.6 K to 2.1 K (+33.33 %) |
| May 24 2018 | KMPH | KEMPHARM, INC | Saluri Joseph | Director | Option Exercise | A | 6.10 | 15,000 | 91,500 | 15,000 | |
| May 24 2018 | KMPH | KEMPHARM, INC | Tierney David S | Director | Option Exercise | A | 6.10 | 15,000 | 91,500 | 15,000 | |
| May 24 2018 | KMPH | KEMPHARM, INC | Thompson Danny L | Director | Option Exercise | A | 6.10 | 15,000 | 91,500 | 15,000 | |
| May 24 2018 | KMPH | KEMPHARM, INC | Plooster Matthew R | Director | Option Exercise | A | 6.10 | 15,000 | 91,500 | 15,000 | |
| May 24 2018 | KMPH | KEMPHARM, INC | Pascoe Richard W | Director | Option Exercise | A | 6.10 | 15,000 | 91,500 | 15,000 | |
| May 17 2018 | KMPH | KEMPHARM, INC | Cohen Daniel L | EVP, Govt. & Public ... | Buy | P | 6.45 | 200 | 1,290 | 1,450 | 1.3 K to 1.5 K (+16.00 %) |
| May 17 2018 | KMPH | KEMPHARM, INC | Cohen Daniel L | EVP, Govt. & Public ... | Buy | P | 6.45 | 200 | 1,290 | 1,450 | 1.3 K to 1.5 K (+16.00 %) |
| May 17 2018 | KMPH | KEMPHARM, INC | Cohen Daniel L | EVP, Govt. & Public ... | Buy | P | 6.45 | 2,000 | 12,891 | 2,000 | 0 to 2 K |
| May 17 2018 | KMPH | KEMPHARM, INC | Cohen Daniel L | EVP, Govt. & Public ... | Buy | P | 6.45 | 5,500 | 35,450 | 35,500 | 30 K to 35.5 K (+18.33 %) |
| Mar 27 2018 | KMPH | KEMPHARM, INC | Thompson Danny L | Director | Option Exercise | M | 4.65 | 3,333 | 15,498 | 0 | |
| Mar 27 2018 | KMPH | KEMPHARM, INC | Thompson Danny L | Director | Payment of Exercise | F | 7.65 | 2,026 | 15,499 | 14,640 | 16.7 K to 14.6 K (-12.16 %) |
| Mar 27 2018 | KMPH | KEMPHARM, INC | Thompson Danny L | Director | Buy | M | 4.65 | 3,333 | 15,498 | 16,666 | 13.3 K to 16.7 K (+25.00 %) |
| Jan 29 2018 | KMPH | KEMPHARM, INC | Sangiovanni Timothy J. | VP, Corporate Contr ... | Option Exercise | A | 5.50 | 30,000 | 165,000 | 30,000 | |
| Jan 29 2018 | KMPH | KEMPHARM, INC | Guenther Sven | EVP, Research & Dev ... | Option Exercise | A | 5.50 | 75,000 | 412,500 | 75,000 | |
| Jan 29 2018 | KMPH | KEMPHARM, INC | Cohen Daniel L | EVP, Govt. & Public ... | Option Exercise | A | 5.50 | 75,000 | 412,500 | 75,000 | |
| Jan 29 2018 | KMPH | KEMPHARM, INC | Johnson Gordon K | Chief Business Offi ... | Option Exercise | A | 5.50 | 75,000 | 412,500 | 75,000 | |
| Jan 29 2018 | KMPH | KEMPHARM, INC | Clifton R. LaDuane | CFO, Secretary & Tr ... | Option Exercise | A | 5.50 | 75,000 | 412,500 | 75,000 | |
| Jan 29 2018 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Option Exercise | A | 5.50 | 30,000 | 165,000 | 30,000 | |
| Jan 29 2018 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Option Exercise | A | 5.50 | 225,000 | 1,237,500 | 225,000 | |
| Nov 29 2017 | KMPH | KEMPHARM, INC | Cohen Daniel L | EVP, Govt. & Public ... | Gift | G | 0.00 | 1,250 | 0 | 1,250 | 0 to 1.3 K |
| Nov 29 2017 | KMPH | KEMPHARM, INC | Cohen Daniel L | EVP, Govt. & Public ... | Gift | G | 0.00 | 1,250 | 0 | 1,250 | 0 to 1.3 K |
| Nov 29 2017 | KMPH | KEMPHARM, INC | Cohen Daniel L | EVP, Govt. & Public ... | Gift | G | 0.00 | 2,500 | 0 | 30,000 | 32.5 K to 30 K (-7.69 %) |
| Nov 29 2017 | KMPH | KEMPHARM, INC | Cohen Daniel L | EVP, Govt. & Public ... | Buy | P | 3.85 | 2,055 | 7,912 | 32,500 | 30.4 K to 32.5 K (+6.75 %) |
| Nov 29 2017 | KMPH | KEMPHARM, INC | Cohen Daniel L | EVP, Govt. & Public ... | Buy | P | 3.80 | 2,990 | 11,362 | 30,445 | 27.5 K to 30.4 K (+10.89 %) |
| Nov 29 2017 | KMPH | KEMPHARM, INC | Cohen Daniel L | EVP, Govt. & Public ... | Buy | P | 3.75 | 1,310 | 4,913 | 27,455 | 26.1 K to 27.5 K (+5.01 %) |
| Nov 29 2017 | KMPH | KEMPHARM, INC | Cohen Daniel L | EVP, Govt. & Public ... | Buy | P | 3.70 | 1,145 | 4,237 | 26,145 | 25 K to 26.1 K (+4.58 %) |
| Sep 25 2017 | KMPH | KEMPHARM, INC | Clifton R. LaDuane | CFO, Secretary & Tr ... | Buy | P | 3.78 | 300 | 1,133 | 1,575 | 1.3 K to 1.6 K (+23.53 %) |
| Sep 15 2017 | KMPH | KEMPHARM, INC | Delaware Street Capital Master ... | 10% Owner | Buy | P | 3.30 | 138,857 | 458,603 | 1,791,631 | 1.7 M to 1.8 M (+8.40 %) |
| Sep 15 2017 | KMPH | KEMPHARM, INC | Delaware Street Capital Master ... | 10% Owner | Buy | P | 3.25 | 200 | 650 | 1,652,774 | 1.7 M to 1.7 M (+0.01 %) |
| Sep 15 2017 | KMPH | KEMPHARM, INC | Delaware Street Capital Master ... | 10% Owner | Buy | P | 3.25 | 186,831 | 607,574 | 1,652,574 | 1.5 M to 1.7 M (+12.75 %) |
| Aug 25 2017 | KMPH | KEMPHARM, INC | Cohen Daniel L | EVP, Govt. & Public ... | Buy | P | 2.58 | 5,000 | 12,882 | 25,000 | 20 K to 25 K (+25.00 %) |
| Aug 25 2017 | KMPH | KEMPHARM, INC | Johnson Gordon K | Chief Business Offi ... | Buy | P | 2.63 | 1,000 | 2,626 | 6,000 | 5 K to 6 K (+20.00 %) |
| Aug 25 2017 | KMPH | KEMPHARM, INC | Johnson Gordon K | Chief Business Offi ... | Buy | P | 2.61 | 2,000 | 5,227 | 5,000 | 3 K to 5 K (+66.67 %) |
| Aug 25 2017 | KMPH | KEMPHARM, INC | Johnson Gordon K | Chief Business Offi ... | Buy | P | 2.55 | 1,000 | 2,550 | 3,000 | 2 K to 3 K (+50.00 %) |
| Jun 21 2017 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Gift | G | 0.00 | 18,194 | 0 | 141,356 | 159.6 K to 141.4 K (-11.40 %) |
| Jun 21 2017 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Gift | G | 0.00 | 32,269 | 0 | 53,638 | 85.9 K to 53.6 K (-37.56 %) |
| Jun 21 2017 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Gift | G | 0.00 | 18,194 | 0 | 1,647,806 | 1.6 M to 1.6 M (+1.12 %) |
| Jun 21 2017 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Gift | G | 0.00 | 32,269 | 0 | 1,629,612 | 1.6 M to 1.6 M (+2.02 %) |
| Jun 21 2017 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Buy | P | 3.45 | 8,000 | 27,592 | 17,050 | 9.1 K to 17.1 K (+88.40 %) |
| Jun 21 2017 | KMPH | KEMPHARM, INC | Clifton R. LaDuane | CFO, Secretary & Tr ... | Buy | P | 3.30 | 275 | 908 | 1,275 | 1,000 to 1.3 K (+27.50 %) |
| May 26 2017 | KMPH | KEMPHARM, INC | Cohen Daniel L | EVP, Govt. & Public ... | Buy | P | 4.14 | 526 | 2,180 | 20,000 | 19.5 K to 20 K (+2.70 %) |
| May 26 2017 | KMPH | KEMPHARM, INC | Cohen Daniel L | EVP, Govt. & Public ... | Buy | P | 4.10 | 1,974 | 8,093 | 19,474 | 17.5 K to 19.5 K (+11.28 %) |
| May 24 2017 | KMPH | KEMPHARM, INC | Tierney David S | Director | Option Exercise | A | 3.95 | 10,000 | 39,500 | 10,000 | |
| May 24 2017 | KMPH | KEMPHARM, INC | Thompson Danny L | Director | Option Exercise | A | 3.95 | 10,000 | 39,500 | 10,000 | |
| May 24 2017 | KMPH | KEMPHARM, INC | Saluri Joseph | Director | Option Exercise | A | 3.95 | 10,000 | 39,500 | 10,000 | |
| May 24 2017 | KMPH | KEMPHARM, INC | Plooster Matthew R | Director | Option Exercise | A | 3.95 | 10,000 | 39,500 | 10,000 | |
| May 24 2017 | KMPH | KEMPHARM, INC | Pascoe Richard W | Director | Option Exercise | A | 3.95 | 10,000 | 39,500 | 10,000 | |
| Mar 31 2017 | KMPH | KEMPHARM, INC | Cohen Daniel L | EVP, Govt. & Public ... | Buy | P | 4.70 | 1,000 | 4,700 | 17,500 | 16.5 K to 17.5 K (+6.06 %) |
| Mar 31 2017 | KMPH | KEMPHARM, INC | Cohen Daniel L | EVP, Govt. & Public ... | Buy | P | 4.33 | 1,500 | 6,502 | 16,500 | 15 K to 16.5 K (+10.00 %) |
| Mar 27 2017 | KMPH | KEMPHARM, INC | Clifton R. LaDuane | CFO, Secretary & Tr ... | Buy | P | 4.24 | 100 | 424 | 1,000 | 900 to 1,000 (+11.11 %) |
| Mar 27 2017 | KMPH | KEMPHARM, INC | Clifton R. LaDuane | CFO, Secretary & Tr ... | Buy | P | 4.24 | 900 | 3,819 | 900 | 0 to 900 |
| Mar 24 2017 | KMPH | KEMPHARM, INC | Mickle Christal M M | VP, Operations & Pr ... | Gift | G | 0.00 | 71,262 | 0 | 159,550 | 230.8 K to 159.6 K (-30.87 %) |
| Mar 24 2017 | KMPH | KEMPHARM, INC | Mickle Christal M M | VP, Operations & Pr ... | Gift | G | 0.00 | 144,905 | 0 | 85,907 | 230.8 K to 85.9 K (-62.78 %) |
| Mar 24 2017 | KMPH | KEMPHARM, INC | Mickle Christal M M | VP, Operations & Pr ... | Gift | G | 0.00 | 71,262 | 0 | 1,597,343 | 1.5 M to 1.6 M (+4.67 %) |
| Mar 24 2017 | KMPH | KEMPHARM, INC | Mickle Christal M M | VP, Operations & Pr ... | Gift | G | 0.00 | 144,905 | 0 | 1,526,081 | 1.4 M to 1.5 M (+10.49 %) |
| Mar 24 2017 | KMPH | KEMPHARM, INC | Mickle Christal M M | VP, Operations & Pr ... | Buy | P | 4.10 | 2,000 | 8,199 | 9,050 | 7.1 K to 9.1 K (+28.37 %) |
| Mar 24 2017 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Gift | G | 0.00 | 71,262 | 0 | 159,550 | 230.8 K to 159.6 K (-30.87 %) |
| Mar 24 2017 | KMPH | KEMPHARM, INC | Mickle Travis C | President & CEO | Gift | G | 0.00 | 144,905 | 0 | 85,907 | 230.8 K to 85.9 K (-62.78 %) |